Healthy Extracts Inc. Announces 2020 Year-End Accomplishments, Annual Revenue Up 71%

Rhea-AI Summary

Healthy Extracts Inc. (OTCQB: HYEX) reported a significant 71% revenue increase for the year ended December 31, 2020, totaling $1.28 million, up from $748,377 in 2019. This growth was fueled by a shift to health nutrition products and the elimination of convertible debt, raising shareholder equity by $3.7 million. Key accomplishments in 2020 included the launch of innovative health products and the completion of pivotal clinical studies. The company rebranded and upgraded to OTCQB, signaling a positive outlook for future expansion and growth.

Positive

• Revenue increased by 71% to $1.28 million in 2020.
• Net shareholder equity rose by $3.7 million.
• Eliminated all convertible debt, improving financial health.
• Introduced innovative products like Clinical Immune and Fuel4Thought.
• Successful clinical studies published in reputable journals.

Negative

• None.

LAS VEGAS, March 09, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Healthy Extracts Inc. (OTCQB: HYEX) (the “Company”), a leading developer and manufacturer of heart health, brain health and supplementary technologies, announces its year-end results for 2020 and a list of key accomplishments.

The Company reported revenue increases of 71% to $1,276,559 for the 12 months ended Dec. 31, 2020, compared to revenues of $748,377 reported for the 12-month period ended Dec. 31, 2019, with a net shareholder equity increase of $3.7 million. The Company attributes the increases to the transition to its new business selling health nutrition products, seeing favorable results despite the effects of COVID. The Company also eliminated its convertible debt.

“I am extremely excited about 2021 and our ‘Live Life Young Again’ strategy. Our name and ticker symbol changes were finalized last week, transitioning to Healthy Extracts Inc, (OTCQB:HYEX), which aligns us with our corporate objectives,” stated Duke Pitts, president. “Our 2020 results demonstrate continued momentum for the Company.”

Key 2020 Activities:

• Gross revenue was up 71% in 2020, even with some continued negative effects of COVID.
• Healthy Extracts Inc. (HYEX) name change from Grey Cloak Tech to better align its companies.
• Full reporting and upgraded to the OTCQB in October 2020.
• Independent report conducted by Trickle Research projecting positive stock growth.
• Company eliminated all convertible debt.
• Net shareholder equity increase of $3.7 million.
• Acquired Ultimate Brain Nutrients for its breakthrough brain products, including six patents (2 issued, 4 pending) and its proprietary formulations.
• Introduction of the revolutionary Clinical Immune, the only immune product formulated and clinically proven focusing on heart and respiratory immune health.
• Key clinical studies on its proprietary unique Fuel4Thought Brain Booster product, with sales beginning in Q2.
• Pilot study completed on the Company’s Fuel4Thought Migraine formulation with great results; study was published in the renowned World Journal of Advanced Research and Reviews.
• Release of HerHeart, the only cardiovascular product designed just for women; positive clinical trial results published in Annals of Women's Health. Cardiovascular disease is and will likely remain the No. 1 cause of death in the U.S. for women and men.
  

About Healthy Extracts Inc.
Healthy Extracts Inc. (OTCQB: HYEX), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural-ingredient cardiovascular and neuro products. For more information, visit the company’s website:
www.healthyextractsinc.com

About Ultimate Brain Nutrients
Ultimate Brain Nutrients (UBN), a subsidiary of Healthy Extracts Inc., is a science-based company that develops unique, plant-based superior health technology neuro-products that improve brain health, including memory, cognition, focus and neuro-energy. UBN’s KETONOMICS® proprietary formulations – targeting brain activity, headache and cognitive behavior – provide multiple intellectual property license opportunities for monetizing the company’s portfolio. License opportunities include multiple beverage formats, individual products, proprietary mixtures and other food platforms. UBN has five unique formulation patents – two issued and four pending. Learn more at www.ubnutrients.com.

About BergaMet NA
BergaMet NA is a provider of nutraceutical natural heart health supplements. Based in Nevada, BergaMet researches and develops proprietary, natural, plant-based formulations. BergaMet NA is the only Citrus Bergamot SuperFruit™ heart health supplement backed by 17 clinical studies. The BergaMet brand supplement boasts the highest quality and concentration of polyphenols and flavonoids available anywhere in the world. It is also the only bergamot supplement approved by the prestigious Accademia del Bergamotto of Italy. BergaMet NA is the only company authorized to manufacture, distribute and sell these products in the United States, Canada and Mexico. BergaMet also provides sales and distribution of natural products that feature superior health technologies based on clinical and doctor-supported evidence for maintaining a healthy immune system and improving metabolic syndrome. Learn more at www.bergametna.com.

Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K, filed with the SEC on Feb 19, 2021, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Healthy Extracts Inc.:
Info@healthyextractsinc.com

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

FAQ

What were Healthy Extracts Inc.'s revenue figures for 2020?

Healthy Extracts Inc. reported revenues of $1.28 million for 2020, a 71% increase from the previous year.

How much did net shareholder equity increase for HYEX in 2020?

Net shareholder equity for Healthy Extracts Inc. increased by $3.7 million in 2020.

What major financial change did Healthy Extracts Inc. achieve in 2020?

The company eliminated all convertible debt in 2020, enhancing its financial stability.

What innovative products did Healthy Extracts Inc. launch in 2020?

The company launched Clinical Immune and Fuel4Thought, targeting heart and brain health.